Management of Febrile Neutropenia in a Tropical Country.
作者信息
Rego Eduardo Magalhães
机构信息
Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, SP, Brazil; Instituto D´Or de Pesquisa e Ensino (IDOR), São Paulo, SP, Brazil; Laboratório de Investigações Médicas 31, Faculdade de Medicina da Universidade de São Paulo (LIM 31 FM USP), São Paulo, SP, Brazil.
出版信息
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S1-S2. doi: 10.1016/j.htct.2024.11.118.
Abstract
摘要
相似文献
1
Management of Febrile Neutropenia in a Tropical Country.热带国家发热性中性粒细胞减少症的管理
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S1-S2. doi: 10.1016/j.htct.2024.11.118.
2
Febrile neutropenia in the tropics: a description of clinical and microbiological findings and their impact on inappropriate therapy currently used at an oncological reference center in Colombia.热带地区的发热性中性粒细胞减少症：对临床和微生物学检查结果的描述及其对哥伦比亚一家肿瘤学参考中心目前使用的不恰当治疗方法的影响。
Biomedica. 2013 Jan-Mar;33(1):70-7. doi: 10.1590/S0120-41572013000100009.
3
Can complications in febrile neutropenia be predicted? Report from a developing country.发热性中性粒细胞减少症的并发症能够被预测吗？来自一个发展中国家的报告。
Support Care Cancer. 2017 Nov;25(11):3523-3528. doi: 10.1007/s00520-017-3776-7. Epub 2017 Jun 11.
4
Outpatient management of febrile neutropenia in children with cancer.癌症患儿发热性中性粒细胞减少症的门诊管理
Paediatr Drugs. 2003;5(7):443-55. doi: 10.2165/00128072-200305070-00002.
5
Management of febrile neutropenia in patients receiving chemotherapy for solid tumors: a retrospective study of twenty cases from the radiotherapy centre, Accra, Ghana.实体瘤化疗患者发热性中性粒细胞减少症的管理：来自加纳阿克拉放疗中心的20例回顾性研究
West Afr J Med. 2010 Sep-Oct;29(5):303-8. doi: 10.4314/wajm.v29i5.68249.
6
Approach to febrile neutropenia in the general paediatric setting.一般儿科环境中发热性中性粒细胞减少症的处理方法。
Paediatr Child Health. 2007 Jan;12(1):19-21. doi: 10.1093/pch/12.1.19.
7
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis.发热性中性粒细胞减少症的变化面貌——从单一疗法到霉菌感染再到黏膜炎。黏膜炎：从发热性中性粒细胞减少症到发热性黏膜炎。
J Antimicrob Chemother. 2009 May;63 Suppl 1:i36-40. doi: 10.1093/jac/dkp081.
8
Can febrile neutropenia re-invent its self?发热性中性粒细胞减少症能自我重塑吗？
Curr Opin Oncol. 2025 Mar 1;37(2):163-167. doi: 10.1097/CCO.0000000000001116. Epub 2025 Jan 15.
9
Prospective cohort study of febrile neutropenia in breast cancer patients with neoadjuvant and adjuvant chemotherapy: CSPOR-BC FN study.新辅助和辅助化疗的乳腺癌患者发热性中性粒细胞减少症的前瞻性队列研究：CSPOR-BC FN研究。
Jpn J Clin Oncol. 2016 Jul;46(7):692-5. doi: 10.1093/jjco/hyw045. Epub 2016 May 9.
10
A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period.一项为期 5 年的阿根廷 515 例发热性中性粒细胞减少症的多中心前瞻性研究。
PLoS One. 2019 Oct 31;14(10):e0224299. doi: 10.1371/journal.pone.0224299. eCollection 2019.
本文引用的文献
1
Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH.发热性中性粒细胞减少症的管理：巴西血液学、输血与细胞治疗协会（ABHH）共识
Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S346-S361. doi: 10.1016/j.htct.2024.11.119. Epub 2024 Dec 18.
2
Systematic Review of Candidemia in Brazil: Unlocking Historical Trends and Challenges in Conducting Surveys in Middle-Income Countries.巴西念珠菌血症的系统评价：揭示中等收入国家开展调查的历史趋势与挑战
Mycopathologia. 2024 Jun 28;189(4):60. doi: 10.1007/s11046-024-00867-w.
3
An Emergent Change in Epidemiologic and Microbiological Characteristics of Bloodstream Infections in Adults With Febrile Neutropenia Resulting From Chemotherapy for Acute Leukemia and Lymphoma at Reference Centers in Chile, Ecuador, and Peru.智利、厄瓜多尔和秘鲁参考中心接受化疗的急性白血病和淋巴瘤成人发热性中性粒细胞减少症患者血流感染的流行病学和微生物学特征的紧急变化。
Open Forum Infect Dis. 2024 Feb 1;11(3):ofae052. doi: 10.1093/ofid/ofae052. eCollection 2024 Mar.
4
Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting.资源受限环境下急性髓系白血病诱导相关死亡的预测因素
Ann Hematol. 2022 Jan;101(1):147-154. doi: 10.1007/s00277-021-04687-6. Epub 2021 Oct 21.
5
Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach.采用抗真菌诊断驱动方法管理的血液系统恶性肿瘤患者和造血干细胞移植受者侵袭性真菌病的流行病学
J Fungi (Basel). 2021 Jul 23;7(8):588. doi: 10.3390/jof7080588.
6
Improving Pediatric Cancer Care Disparities Across the United States-Mexico Border: Lessons Learned from a Transcultural Partnership between San Diego and Tijuana.改善美国-墨西哥边境地区儿科癌症护理差距：圣地亚哥和蒂华纳之间跨文化合作关系的经验教训。
Front Public Health. 2015 Jun 22;3:159. doi: 10.3389/fpubh.2015.00159. eCollection 2015.
7
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.全反式维甲酸联合柔红霉素或伊达比星用于急性早幼粒细胞白血病的风险适应性治疗：PETHEMA LPA - 2005和IC - APL研究的配对分析
Ann Hematol. 2015 Aug;94(8):1347-56. doi: 10.1007/s00277-015-2393-0. Epub 2015 May 15.
8
Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients.急性髓细胞白血病和造血细胞移植受者侵袭性镰刀菌病的危险因素。
Clin Infect Dis. 2015 Mar 15;60(6):875-80. doi: 10.1093/cid/ciu947. Epub 2014 Nov 25.
Zotero 插件